4QFY18 earnings contraction. Inari Amertron Bhd’s (Inari) reported 4QFY18 earnings of RM57.1m. After excluding exceptional items amounting to -RM19.8m, 4QFY18 normalised earnings came in at RM37.3m (-35.4%yoy). The bulk of the exceptional items pertained to gain on disposal of Ceedtec’s project and asset amounting to RM11.0m. The reduction in earnings was mainly due to seasonally lower demand of the group’s product and increase in effective income tax rate.
Full year FY18 normalised earnings charted double digit growth. Cumulatively, full year FY18 normalised earnings grew by +32.5%yoy to RM255.5m. This was mainly premised on increase in demand of factory output and changes in product mix. However, the group’s FY18 financial performance trailed behind ours and consensus’ expectations, accounting for 92.9% and 94.3% of respective full year FY18 earnings forecasts.
Dividend. As expected, Inari reduced its 4QFY18 dividend payment to 2.0sen from 2.8sen as at 4QFY17. This led to full year FY18 dividend payment of 8.4sen (FY17: 9.8sen). We view that the group is capping the dividend payout in order to allocate more cash to fund future capital expenditure (capex) needs. Note that during the quarter-in-review, Inari’s cash balance expanded by +16.3%yoy to RM530.0m from RM455.3m recorded as at 4QFY17.
Impact on earnings. We are reducing FY19 earnings by -5.6% after adjusting downward our revenue growth assumption and imputing slightly higher effective tax rate to better reflect the results thus far.
Target Price. We are rolling forward our valuation base year to FY20 and derive a new target price of RM2.25 (previously RM2.08). This is premised on FY20 EPS of 10.6sen pegged to an unchanged forward PER of 21.2x. Our target PER is based on its 5-year historical high rolling PER.
Maintain NEUTRAL. Inari’s strategic positioning within the semiconductor value chain has proven to be in favour of the group. The group’s various core business segments (i.e. wireless RF, optoelectronics and iris scan product) have been recording better financial performance due to healthier demand of its product. The favourable mix of the group’s product offerings has also lead to healthier profit margin. However, we expect the earnings growth rate to decelerate in view of a high base effect. Meanwhile, in anticipation of hefty future capital spending, we expect dividend yield to remain below four percent. On another note, we view that the stock valuation of more than 22x is currently stretched. All factors considered, we are maintaining our NEUTRAL recommendation on the stock.
Source: MIDF Research - 29 Aug 2018
Chart | Stock Name | Last | Change | Volume |
---|
2024-11-14
INARI2024-11-14
INARI2024-11-14
INARI2024-11-14
INARI2024-11-12
INARI2024-11-12
INARI2024-11-12
INARI2024-11-11
INARI2024-11-11
INARI2024-11-08
INARI2024-11-08
INARI2024-11-08
INARI2024-11-06
INARI2024-11-06
INARI2024-11-05
INARI2024-11-05
INARI2024-11-05
INARI2024-11-04
INARICreated by sectoranalyst | Nov 15, 2024
Created by sectoranalyst | Nov 15, 2024
Created by sectoranalyst | Nov 15, 2024
Created by sectoranalyst | Nov 13, 2024
Created by sectoranalyst | Nov 11, 2024